Past studies have shown that cyclin-dependent kinase 4 and 6 (CDK4 and CDK6) are generally overexpressed in various tumor cells and related to the increase of cyclin A in head and neck carcinomas [30]. This evidence concerns the gene CDK6 and head and neck carcinoma.